Viewing Study NCT00022360


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 5:45 AM
Study NCT ID: NCT00022360
Status: COMPLETED
Last Update Posted: 2013-06-18
First Post: 2001-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Taurolidine in Treating Patients With Recurrent or Progressive Glioma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module